Volume 10, Issue 2 (May 2022)
Res Mol Med (RMM) 2022, 10(2): 65-84 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Arianfar F, Tarighi P, Shariatpanahi M, Mousavi Esfahani S M, Mottaghi-Dastjerdi N. Biopharmaceuticals and Nutraceuticals Produced in Yeasts and the Clinical Management Related to COVID-19 Disease. Res Mol Med (RMM) 2022; 10 (2) :65-84
URL: http://rmm.mazums.ac.ir/article-1-456-en.html
URL: http://rmm.mazums.ac.ir/article-1-456-en.html
Farzane Arianfar1 
, Parastoo Tarighi1 , Marjan Shariatpanahi2 , Seyedeh Mona Mousavi Esfahani1 , Negar Mottaghi-Dastjerdi3 
, Parastoo Tarighi1 , Marjan Shariatpanahi2 , Seyedeh Mona Mousavi Esfahani1 , Negar Mottaghi-Dastjerdi3
1- Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
2- Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran
3- Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran ,Mottaghi.n@iums.ac.ir
2- Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran
3- Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran ,
Abstract: (1660 Views)
Recently, the market demand for biopharmaceuticals and nutraceuticals has increased. Consequently, high-volume production strategies have also drawn a lot of attention. The invention and development of recombinant DNA technology, using various hosts from bacteria to mammalian cells, have led to the industrial-scale manufacture of many valuable pharmaceutical products. Among the hosts, yeasts have a special place due to their numerous benefits. The present study deals with commercial yeast-derived biopharmaceuticals and laboratory-scale yeast-extracted nutraceuticals. It represents the biotechnological potential of yeasts to meet the market's needs in this area. Besides, considering the COVID-19 pandemic, the applications of yeast hosts for the clinical management of this disease have been briefly discussed.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
